# Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults

> **NCT03363178** · PHASE1 · UNKNOWN · sponsor: **Green Cross Corporation** · enrollment: 20 (estimated)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** GC3107

## Key facts

- **NCT ID:** NCT03363178
- **Lead sponsor:** Green Cross Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-14
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-03-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03363178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03363178, "Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03363178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*